社区歌唱干预对产后抑郁症状的临床、实施与成本效果:SHAPER-PND随机对照试验
两组抑郁症状至第10周均减轻,但歌唱组在第20周和第36周EPDS评分更低,且保留率更高、接受度/适宜度/可行性更好,并具成本效果。
要点
- 歌唱组第20周EPDS为10.7 vs 对照组12.2,差异有统计学意义。
- 歌唱组第36周EPDS为9.85 vs 对照组11.4,差异有统计学意义。
- 歌唱组研究保留率77% vs 57%,接受度、适宜度、可行性均更高。
核心结论
- M4M歌唱干预对产后抑郁症状有较持久效果,且比现有社区活动更适宜,具成本效果。
研究设计与样本
- 在第6、10、20、36周复评抑郁、医疗服务使用及EQ5D-3健康相关生活质量,第6周评估接受度、适宜度与可行性。
主要发现
- 两组抑郁症状至第10周均减轻,但歌唱组第20周EPDS为10.7 vs 对照组12.2(均差95%CI [-2.96, -0.22],P=0.023)。
- 歌唱组第36周EPDS为9.85 vs 对照组11.4(均差95%CI [-2.93, -0.19],P=0.026)。
- 歌唱组保留率77% vs 57%(χ2(1)=12.92,P<0.001)。
- 歌唱组接受度4.75 vs 4.0(95%CI [0.25, 0.83],U=2436.5,P<0.001)、适宜度4.25 vs 3.88(95%CI [0.12, 0.62],U=2241.5,P<0.001)、可行性4.75 vs 4.0(95%CI [0.41, 0.91],U=2568.0,P<0.001)均更高。
- M4M与额外15天健康相关,具成本效果(每对母婴£126-539)。
关键数值与推荐
- 产后抑郁症状入组标准为EPDS评分≥10。
- 歌唱组第20周EPDS 10.7 vs 对照组12.2,P=0.023;第36周9.85 vs 11.4,P=0.026。
- 歌唱组保留率77% vs 57%,P<0.001。
- 接受度、适宜度、可行性均P<0.001,歌唱组更高。
- 成本效果为每对母婴£126-539。
临床怎么用
- 对于有产后抑郁症状且对常规治疗存在障碍的母亲,可考虑转介至M4M类社区歌唱干预。
- 歌唱干预可作为产后抑郁症状的辅助或替代选择,尤其适合追求高接受度与可行性的母亲。
- 干预效果在20周和36周仍可见,提示需关注长期随访与维持。
局限性
- 原文未报告盲法、长期随访脱落原因及成本效果分析的具体方法学细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postnatal depression (PND) affects up to one in four mothers. However, they may experience barriers to access to conventional treatments, indicating a need for alternatives such as arts-based interventions. A previous trial showed that a 10-week singing intervention could alleviate symptoms of PND. AIMS: To evaluate, in a larger sample and across a longer timeframe than previously, the clinical effectiveness, implementation effectiveness and cost-effectiveness of the Melodies for Mums (M4M) singing intervention for symptoms of PND. METHOD: One-hundred and ninety-nine mothers experiencing symptoms of PND (Edinburgh Postnatal Depression Scale score ≥10) and their babies were randomised to 10 weeks of in-person singing sessions (M4M, n = 133) or an active control (existing community-based mother-baby activities, n = 66). Mothers were re-assessed at weeks 6, 10, 20 and 36 for depression, healthcare use for themselves and their babies, and health-related quality of life according to the EQ5D-3. The perceived acceptability (Acceptability of Intervention Measure), appropriateness (Intervention Appropriateness Measure) and feasibility (Feasibility of Intervention Measure) of the activity were also assessed at week 6. Trial registration number: NCT04834622. RESULTS: Mothers in both groups experienced attenuation of depressive symptoms by week 10; however, those in the singing group maintained lower EPDS scores than those in the control group at week 20 (10.7 v. 12.2 (mean difference 95% CI [-2.96, -0.22]), P = 0.023) and week 36 (9.85 v. 11.4 [-2.93, -0.19], P = 0.026). Mothers in the singing group were also more likely to remain in the study (77 v. 57%, χ2(1) = 12.92, P < 0.001) and found their programme more acceptable (4.75 v. 4.0 [0.25, 0.83], U = 2436.5, P < 0.001), appropriate (4.25 v. 3.88 [0.12, 0.62], U = 2241.5, P < 0.001) and feasible (4.75 v. 4.0 [0.41, 0.91], U = 2568.0, P < 0.001). Finally, M4M was associated with 15 extra days of health and was found to be cost-effective (£126-539 per dyad). CONCLUSION: M4M had a long-lasting effect on symptoms of PND and was perceived to be more suitable than existing activities; thus, M4M represents a worthwhile investment for healthcare systems as an intervention for mothers experiencing symptoms of PND.
引用
- Bind RH, Lawrence AJ, Estevao C, et al. Clinical effectiveness, implementation effectiveness and cost-effectiveness of a community singing intervention for postnatal depressive symptoms, SHAPER-PND: randomised controlled trial. Br J Psychiatry. 2025. PMID: 41087020. doi:10.1192/bjp.2025.10377
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。